Article

Want to learn more about cervical cancer?

Author(s):

Elizabeth Whittington

In honor of Cervical Cancer Awareness Month, several organizations are sponsoring a tweet chat on the disease and one of its main causes – the human papillomavirus (HPV).When: Jan. 15, 1 p.m ET

Where: Twitter #cervicalcaThe chat is hosted by Montefiore Medical Center (@MontefioreNews), in partnership with the Foundation for Women's Cancer (@GYNCancer) and the American Cancer Society (@americancancer) of New York and New Jersey (@cancerNYNJ). Gynecological oncologist, Mark Einstein, MD, will be on hand to address prevention, diagnosis and treatment questions. Other than it being January, it's a timely topic in light of the recent Annual Report to the Nation on the Status of Cancer report coming out yesterday highlighting the dangers of HPV and the importance of vaccination. [Report to the nation on cancer shows mortality drops, HPV-related cancers on the rise" Jan. 7, 2013]What will you ask?

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of 2 doctors and text.
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Image of two people.
Image of doctor.
Related Content
The FDA granted fast track designation to RAD101 to improve detection of recurrent brain metastases: © stock.adobe.com.
June 13th 2025

FDA Grants Fast Track Designation to RAD101 in Brain Metastases

Spencer Feldman
The FDA granted fast track designation to RAD101, an experimental imaging agent, to improve detection of recurrent brain metastases.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Image of Patti.
June 12th 2025

Beyond Treatment: How Support Groups Helped Me Embrace My New Normal

Patti McGee
Joining support groups after cancer treatment helped me heal emotionally, connect with others who understood and embrace a new, meaningful normal.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Graphic that reads "FDA APPROVED" resembling a stamp of approval
June 12th 2025

FDA Approves UGN-102 For Some With Bladder Cancer

Bridget Hoyt
The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer.
Georgia Hurst is a fierce patient advocate for those with Lynch syndrome. Catch up on all of Georgia's blogs here!
June 12th 2025

Don’t Miss Your Shot: A Letter to My Newly Diagnosed Self

Georgia Hurst
Eminem’s lyric about having “one shot” stayed with me, and writing this letter to my newly diagnosed self, reminds me how that mindset saved my life.